Home › Calculator › PASG Dividend Calculator 2026
PASG Dividend DRIP Calculator 2026
43.06% YieldHealthcarePassage Bio, Inc. · NASDAQ
Price: $4.65 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When PASG pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your PASG snowball 📈
$10,000 in PASG → $359.0K in 10 years · $9,004.23/month
About Passage Bio, Inc. (PASG) — Dividend Analysis 2026
Passage Bio, Inc. is a biopharmaceutical company dedicated to pioneering genetic therapies for conditions affecting the central nervous system. Their advanced pipeline includes PBGM01, designed to treat infantile GM1 gangliosidosis by utilizing a proprietary AAVhu68 capsid to deliver a functional GLB1 gene, which codes for the lysosomal acid beta-galactosidase enzyme, to both the brain and peripheral tissues. Another key program, PBFT02, employs an AAV1 capsid to introduce a functional granulin (GRN) gene, encoding progranulin (PGRN), to the brain as a treatment for FTD-GRN. Additionally, PBKR03 is under development for infantile Krabbe disease, leveraging a proprietary AAVhu68 capsid to deliver a functional GALC gene, responsible for producing the hydrolytic enzyme galactosylceramidase, to the brain and surrounding tissues. The company's portfolio also features PBML04 for metachromatic leukodystrophy, PBAL05 for amyotrophic lateral sclerosis, and PBCM06 for Charcot-Marie-Tooth Type 2A. Passage Bio maintains a significant research collaboration with the Trustees of the University of Pennsylvania's Gene Therapy Program, alongside a development services and clinical supply agreement with Catalent Maryland, Inc. Established in 2017, the company's headquarters are located in Philadelphia, Pennsylvania.
Compare PASG with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full PASG DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open PASG position with:
🌍 PASG Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold PASG.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 43.06% | 40.26% | $4,306 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 36.60% | 33.80% | $3,660 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 34.45% | 31.65% | $3,445 / yr |
| 🇬🇧 UK ISA | 0% | 43.06% | 40.26% | $4,306 / yr |
| 🇬🇧 UK Taxable | 8.75% | 39.29% | 36.49% | $3,929 / yr |
| 🇨🇦 TFSA | 0% | 43.06% | 40.26% | $4,306 / yr |
| 🇨🇦 CA Taxable | 25% | 32.30% | 29.50% | $3,230 / yr |
| 🇦🇺 Super (pension) | 15% | 36.60% | 33.80% | $3,660 / yr |
| 🇦🇺 AU Taxable | 30% | 30.14% | 27.34% | $3,014 / yr |
| 🇩🇪 DE Taxable | 26.375% | 31.70% | 28.90% | $3,170 / yr |
| 🇫🇷 FR Taxable | 30% | 30.14% | 27.34% | $3,014 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 PASG Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 PASG Dividend Payment Schedule
PASG pays quarterly — 4 times per year. Next ex-div: TBD.
📊 PASG vs Healthcare Benchmarks
How PASG compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for PASG sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ PASG Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Buy | 2026-06-25 | 50,055 | $4.12 | $206.1K | ||
| A-Award | 2026-05-19 | 10,539 | $5.08 | $53.5K | ||
| A-Award | 2026-05-19 | 10,539 | $5.08 | $53.5K | ||
| A-Award | 2026-05-19 | 10,539 | $5.08 | $53.5K | ||
| A-Award | 2026-05-19 | 10,539 | $5.08 | $53.5K | ||
| A-Award | 2026-05-19 | 10,539 | $5.08 | $53.5K | ||
| A-Award | 2026-05-19 | 10,539 | $5.08 | $53.5K | ||
| A-Award | 2026-03-16 | 15,610 | $7.64 | $119.3K | ||
| A-Award | 2026-03-16 | 58,000 | $7.64 | $443.1K | ||
| M-Exempt | 2026-01-08 | 10,000 | — | — |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Insiders are net buyers — historically a positive signal for dividend sustainability. Last purchase: 2026-06-25
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the PASG dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Passage Bio, Inc. (PASG) is currently trading at $4.65, trading near its 52-week low. The current dividend yield is 43.06% based on an annual payout of $2.00 per share.
PASG (Passage Bio, Inc.) — 43.06% Dividend Yield Analysis
Passage Bio, Inc. (PASG) is a healthcare stock currently trading at $4.64 with a dividend yield of 43.06%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (43.06%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.